
==== Front
BioDrugs
BioDrugs
Biodrugs
1173-8804 1179-190X Springer International Publishing Cham 

410
10.1007/s40259-020-00410-5
Correction
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
http://orcid.org/0000-0003-4978-4072Strand Vibeke vibekestrand@me.com 1 Gonçalves Joao 2 Hickling Timothy P. 3 Jones Heather E. 4 Marshall Lisa 4 Isaacs John D. 5 1 grid.168010.e0000000419368956Division of Immunology/Rheumatology, Stanford University School of Medicine, 306 Ramona Road, Portola Valley, Palo Alto, CA 94028 USA 
2 grid.9983.b0000 0001 2181 4263iMed-Research Institute for Medicines, Faculdade de Farmácia da, Universidade de Lisboa, Lisbon, Portugal 
3 grid.410513.20000 0000 8800 7493Biomedicine Design, Pfizer, Andover, MA USA 
4 grid.410513.20000 0000 8800 7493Inflammation and Immunology, Pfizer, Collegeville, PA USA 
5 grid.420004.20000 0004 0444 2244Institute of Cellular Medicine, Newcastle University and Musculoskeletal Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK 
26 2 2020 
26 2 2020 
2020 
34 2 253 253
© The Author(s) 2020Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.issue-copyright-statement© Springer Nature Switzerland AG 2020
==== Body
Correction to: BioDrugs (2020) 34:27–37 10.1007/s40259-019-00394-x
The article Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents, written by Vibeke Strand, Joao Gonçalves, Timothy P. Hickling, Heather E. Jones, Lisa Marshall and John D. Isaacs, was originally published Online First without Open Access. After publication in volume 34, issue 1, pages 27–37 the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of a Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The original article has been corrected.

